Most life sciences teams exploring Salesforce Agentforce today are using it in non-regulated contexts, such as automating CRM updates, streamlining customer support, accelerating forecasting, or orchestrating marketing data flows. And these multi-agent systems can save hours by handling cross-team work in the background. 

But here’s the catch: what happens when those same agents wander into regulated territory? Suddenly, they’re managing product complaints, flagging deviations, or even putting together CAPA documentation. That’s when the line between “fast and flexible” and “inspection-ready” really matters. In a mixed environment, you can’t just think about speed; you’ve got to think about control.

In this session, we’ll look at how to use Agentforce collectives safely across both non-regulated and GxP-regulated use cases. I’ll start with the good news: exploring how agent collectives are already transforming life sciences operations. Then we’ll dig into the risks of hybrid environments, such as unclear accountability, data flowing where it shouldn’t, black-box decision-making, and the ripple effects of agents retraining or being reassigned. Even simple, non-regulated automations (like CRM workflows) can brush up against regulated data, and if you’re not prepared, that’s a compliance headache waiting to happen.

I’ll share how to scale your guardrails with lighter-touch checks where you'll need agility, and stronger ones where the stakes are higher. We’ll spend time on data lineage, because without transparent hand-offs between agents, there’s no trust and definitely no inspection readiness. 

And yes, we’ll tackle change control, because even “small” updates in non-regulated areas can spill over into GxP workflows and trigger revalidation.

We’ll wrap up with practical ways to keep your multi-agent systems inspection-ready without slowing down innovation. The goal is simple: keep agent collectives safe, compliant, and trusted across your business.

SPEAKER: Rosalind Beasley